[SCHEDULE 13D/A] Abivax S.A. SEC Filing

Rhea-AI Filing Summary

Abivax SA (ABVX) — Schedule 13D/A Amendment No. 3: Sofinnova Crossover I SLP and affiliated reporting persons updated their ownership and disclosed recent open‑market sales of American Depositary Shares. As of September 30, 2025, they report holding 4,334,739 Ordinary Shares, representing approximately 5.6% of shares outstanding, and 8,399,478 voting rights, representing approximately 9.4% of voting rights. The base figures cited are 77,830,067 Ordinary Shares and 89,189,666 voting rights outstanding as of September 30, 2025.

The filing lists sales completed in multiple transactions: on October 28, 2025, 522,948 ADSs at a weighted average price of $94.00 per share and 67,929 ADSs at a weighted average price of $95.42; on October 29, 2025, 606,293 ADSs at a weighted average price of $94.00 and 2,830 ADSs at a weighted average price of $95.34. The reporting persons state the shares were acquired for investment purposes and reserve the right to buy or sell as permitted by law.

Insights

Securities disclosure analyst

Ownership update with disclosed ADS sales; position now 5.6%/9.4%.

Sofinnova reports updated stakes in Abivax SA, citing 4,334,739 Ordinary Shares (about 5.6% of shares) and 8,399,478 voting rights (about 9.4% of voting rights) based on September 30, 2025 tallies. This aligns with routine Schedule 13D updating requirements.

The amendment details open‑market ADS sales on October 28–29, 2025 at weighted average prices of $94.00, $95.42, $94.00, and $95.34. These figures document activity; actual impact depends on subsequent trading and any future changes in ownership.

The filing indicates investment intent while preserving flexibility to transact within legal bounds. Subsequent filings may provide additional detail if holdings change further.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 3)

Abivax SA

(Name of Issuer)

Ordinary Shares, par value (euro)0.01 per share

(Title of Class of Securities)

00370M103

(CUSIP Number)

Armance Bordes
7-11, boulevard Haussmann,
Paris, I0, 75009
33 1 76 23 41 09

John Partigan Lloyd Spencer
Nixon Peabody LLP, 799 9 Street NW Ste 500
Washington, DC, 20001
202-585-8000

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

10/28/2025

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP No. 00370M103

1

Name of reporting person

Sofinnova Crossover I SLP

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

FRANCE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 8,399,478.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 4,334,739.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

8,399,478.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

9.4 %

14

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person:

Note in relation to Items 7 and 8: Sofinnova Partners SAS, a French corporation ("SP SAS"), the management company of Sofinnova Crossover I SLP ("SC"), may be deemed to have sole voting power, and Antoine Papiernik ("Papiernik"), Cedric Moreau ("Moreau"), Kinam Hong ("Hong"), Joseph Anderson ("Anderson") and Jacques Theurillat ("Theurillat"), the members of the investment committee of SC, may be deemed to have shared power to vote these shares. Note in relation to Items 9 and 10: SP SAS, the management company of SC, may be deemed to have sole power to dispose of these shares, and Papiernik, Moreau, Hong, Anderson and Theurillat, the members of the investment committee of SC, may be deemed to have shared power to dispose of these shares. Note in relation to Items 8, 10, 11 and 13: The Reporting Person beneficially owns 4,334,739 Ordinary Shares (including ordinary shares represented by American depositary shares) and has 8,399,478 voting rights related to such shares. The aggregate amount beneficially owned and percent of class reported above are based on the Reporting Person's voting rights and the 89,189,666 voting rights outstanding as of September 30, 2025.

SCHEDULE 13D

CUSIP No. 00370M103

1

Name of reporting person

Sofinnova Partners SAS

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

FRANCE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 8,399,478.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 4,334,739.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

8,399,478.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

9.4 %

14

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person:

Note in relation to Items 7 and 8: SP SAS, the management company of SC, may be deemed to have sole voting power, and Papiernik, Moreau, Hong, Anderson and Theurillat, the members of the investment committee of SC, may be deemed to have shared power to vote these shares. Note in relation to Items 9 and 10: SP SAS, the management company of SC, may be deemed to have sole power to dispose of these shares, and Papiernik, Moreau, Hong, Anderson and Theurillat, the members of the investment committee of SC, may be deemed to have shared power to dispose of these shares. Note in relation to Items 8, 10, 11 and 13: The Reporting Person beneficially owns 4,334,739 Ordinary Shares (including ordinary shares represented by American depositary shares) and has 8,399,478 voting rights related to such shares. The aggregate amount beneficially owned and percent of class reported above are based on the Reporting Person's voting rights and the 89,189,666 voting rights outstanding as of September 30, 2025.

SCHEDULE 13D

CUSIP No. 00370M103

1

Name of reporting person

Antoine Papiernik

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

FRANCE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 8,399,478.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 4,334,739.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

8,399,478.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

9.4 %

14

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person:

Note to Items 7 and 8: SP SAS, the management company of SC, may be deemed to have sole voting power, and Papiernik, a member of the investment committee of SC, may be deemed to have shared power to vote these shares. Note to Items 9 and 10: SP SAS, the management company of SC, may be deemed to have sole power to dispose of these shares, and Papiernik, a member of the investment committee of SC, may be deemed to have shared power to dispose of these shares. Note in relation to Items 8, 10, 11 and 13: The Reporting Person beneficially owns 4,334,739 Ordinary Shares (including ordinary shares represented by American depositary shares) and has 8,399,478 voting rights related to such shares. The aggregate amount beneficially owned and percent of class reported above are based on the Reporting Person's voting rights and the 89,189,666 voting rights outstanding as of September 30, 2025.

SCHEDULE 13D

CUSIP No. 00370M103

1

Name of reporting person

Cedric Moreau

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

FRANCE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 8,399,478.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 4,334,739.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

8,399,478.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

9.4 %

14

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person:

Note to Items 7 and 8: SP SAS, the management company of SC, may be deemed to have sole voting power, and Moreau, a member of the investment committee of SC, may be deemed to have shared power to vote these shares. Note to Items 9 and 10: SP SAS, the management company of SC, may be deemed to have sole power to dispose of these shares, and Moreau, a member of the investment committee of SC, may be deemed to have shared power to dispose of these shares. Note in relation to Items 8, 10, 11 and 13: The Reporting Person beneficially owns 4,334,739 Ordinary Shares (including ordinary shares represented by American depositary shares) and has 8,399,478 voting rights related to such shares. The aggregate amount beneficially owned and percent of class reported above are based on the Reporting Person's voting rights and the 89,189,666 voting rights outstanding as of September 30, 2025.

SCHEDULE 13D

CUSIP No. 00370M103

1

Name of reporting person

Kinam Hong

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 8,399,478.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 4,334,739.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

8,399,478.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

9.4 %

14

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person:

Note to Items 7 and 8: SP SAS, the management company of SC, may be deemed to have sole voting power, and Hong, a member of the investment committee of SC, may be deemed to have shared power to vote these shares. Note to Items 9 and 10: SP SAS, the management company of SC, may be deemed to have sole power to dispose of these shares, and Hong, a member of the investment committee of SC, may be deemed to have shared power to dispose of these shares. Note in relation to Items 8, 10, 11 and 13: The Reporting Person beneficially owns 4,334,739 Ordinary Shares (including ordinary shares represented by American depositary shares) and has 8,399,478 voting rights related to such shares. The aggregate amount beneficially owned and percent of class reported above are based on the Reporting Person's voting rights and the 89,189,666 voting rights outstanding as of September 30, 2025.

SCHEDULE 13D

CUSIP No. 00370M103

1

Name of reporting person

Joseph Anderson

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED KINGDOM

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 8,399,478.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 4,334,739.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

8,399,478.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

9.4 %

14

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person:

Note to Items 7 and 8: SP SAS, the management company of SC, may be deemed to have sole voting power, and Anderson, a member of the investment committee of SC, may be deemed to have shared power to vote these shares. Note to Items 9 and 10: SP SAS, the management company of SC, may be deemed to have sole power to dispose of these shares, and Anderson, a member of the investment committee of SC, may be deemed to have shared power to dispose of these shares. Note in relation to Items 8, 10, 11 and 13: The Reporting Person beneficially owns 4,334,739 Ordinary Shares (including ordinary shares represented by American depositary shares) and has 8,399,478 voting rights related to such shares. The aggregate amount beneficially owned and percent of class reported above are based on the Reporting Person's voting rights and the 89,189,666 voting rights outstanding as of September 30, 2025.

SCHEDULE 13D

CUSIP No. 00370M103

1

Name of reporting person

Jacques Theurillat

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

SWITZERLAND

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 8,399,478.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 4,334,739.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

8,399,478.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

9.4 %

14

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person:

Note to Items 7 and 8: SP SAS, the management company of SC, may be deemed to have sole voting power, and Theurillat, a member of the investment committee of SC, may be deemed to have shared power to vote these shares. Note to Items 9 and 10: SP SAS, the management company of SC, may be deemed to have sole power to dispose of these shares, and Theurillat, a member of the investment committee of SC, may be deemed to have shared power to dispose of these shares. Note in relation to Items 8, 10, 11 and 13: The Reporting Person beneficially owns 4,334,739 Ordinary Shares (including ordinary shares represented by American depositary shares) and has 8,399,478 voting rights related to such shares. The aggregate amount beneficially owned and percent of class reported above are based on the Reporting Person's voting rights and the 89,189,666 voting rights outstanding as of September 30, 2025.

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Ordinary Shares, par value (euro)0.01 per share
(b)	Name of Issuer: Abivax SA
(c)	Address of Issuer's Principal Executive Offices: 7-11, boulevard Haussmann, Paris, FRANCE , 75009.
Item 1 Comment: Introductory Statement: This Amendment No. 3 (this "Amendment"), being filed by Sofinnova Crossover I SLP ("SC"), Sofinnova Partners SAS, a French corporation ("SP SAS"), Antoine Papiernik ("Papiernik"), Cedric Moreau ("Moreau"), Kinam Hong ("Hong"), Joseph Anderson ("Anderson") and Jacques Theurillat ("Theurillat") the members of the investment committee of SC (collectively, the "Listed Persons" and together with SC and SP SAS, the "Reporting Persons"), amends and supplements the Schedule 13D filed with the Securities and Exchange Commission (the "SEC") on October 30, 2023, as amended by Amendment No. 1, filed with the SEC on February 14, 2025, and as further amended by Amendment No. 2, filed with the SEC on July 31, 2025 (collectively, as amended, the "Schedule 13D"). This Schedule 13D relates to the Ordinary Shares, par value EUR0.01 per share (the "Ordinary Shares"), including ordinary shares represented by American Depositary Shares ("ADS"), of Abivax SA, a societe anonyme incorporated under the laws of the French Republic (the "Issuer"). Except as specifically provided herein, this Amendment No. 3 does not modify any of the information previously reported in the Schedule 13D. Capitalized terms used herein shall have the meanings ascribed to them in the Schedule 13D.
Item 2.	Identity and Background
(d)	During the last five years, none of the Reporting Persons has been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors).
(e)	During the last five years, none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
Item 4.	Purpose of Transaction
	Item 4 of the Schedule 13D is hereby amended and supplemented as follows: SC sold the amounts of ADS on the date and at the price set forth below in open market transactions. All daily sales of the shares were sold in multiple transactions at varying prices. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this Schedule 13D. October 28, 2025: - 522,948 ADSs at a weighted average price of $94.00 per share (multiple transactions at prices ranging from $94.00 to $94.54, inclusive); and - 67,929 ADSs at a weighted average price of $95.42 per share (multiple transactions at prices ranging from $95.25 to $95.68, inclusive). October 29, 2025: - 606,293 ADSs at a weighted average price of $94.00 per share (multiple transactions at prices ranging from $94.00 to $94.93, inclusive); and - 2,830 ADSs at a weighted average price of $95.34 per share (multiple transactions at prices ranging from $95.09 to $95.56, inclusive). All of the Ordinary Shares that are held of record by the Reporting Persons as reported herein were acquired for investment purposes. The Reporting Persons retain the right to change their investment intent, from time to time to acquire additional Ordinary Shares or other securities of the Issuer, or to sell or otherwise dispose of all or part of the Ordinary Shares or other securities of the Issuer, if any, beneficially owned by them, in any manner permitted by law. The Reporting Persons may engage from time to time in ordinary course transactions with financial institutions with respect to the securities described herein. Except as set forth above, none of the Reporting Persons currently has any plans or proposals which would be related to or would result in any of the matters described in Items 4(a)-(j) of the Instructions to Schedule 13D. However, as part of the ongoing evaluation of investment and investment alternatives, the Reporting Persons may consider such matters and, subject to applicable law, may formulate a plan with respect to such matters, and, from time to time, may hold discussions with or make formal proposals to management or the board of directors of the Issuer or other third parties regarding such matters.
Item 5.	Interest in Securities of the Issuer
(a)	Item 5(a) of the Schedule 13D is hereby amended and supplemented as follows: As of October 29, 2025, SC held directly 4,334,739 Ordinary Shares representing approximately 5.6% of the Issuer's outstanding Ordinary Shares and 8,399,478 voting rights representing approximately 9.4% of the Issuer's outstanding voting rights. None of the other Reporting Persons hold any Ordinary Shares or ADSs directly. SP SAS is the management company of SC and may be deemed to have shared voting and investment control over the Ordinary Shares and ADSs held by SC. Each of Antoine Papiernik, Cedric Moreau, Kinam Hong, Joseph Anderson and Jacques Theurillat are the members of the investment committee of SC and may be deemed to have shared voting and investment control over the Ordinary Shares and ADSs held by SC. Each of such individuals disclaims beneficial ownership of such Ordinary Shares and ADSs except to the extent of their pecuniary interest therein. The ownership percentages are based upon 77,830,067 of the Issuer's Ordinary Shares outstanding as of September 30, 2025. The voting percentages are based upon 89,189,666 voting rights outstanding as of September 30, 2025.
(b)	Item 5(b) of the Schedule 13D is hereby amended and supplemented as follows: See the information contained on the cover pages of this Amendment, which is incorporated herein by reference.
(c)	Item 5(c) of the Schedule 13D is hereby amended and supplemented as follows: Except as disclosed herein, there have been no other reportable transactions with respect to the Ordinary Shares or ADSs of the Issuer within the last 60 days by the Reporting Persons.
Item 7.	Material to be Filed as Exhibits.
	EX 99.1 - Agreement regarding filing of joint Schedule 13D (incorporated by reference from Exhibit 99.1 to Schedule 13D filed by the Reporting Persons on October 30, 2023)

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Sofinnova Crossover I SLP

Signature:	/s/ Antoine Papiernik
Name/Title:	Managing Partner
Date:	10/30/2025

Sofinnova Partners SAS

Signature:	/s/ Antoine Papiernik
Name/Title:	Managing Partner
Date:	10/30/2025

Antoine Papiernik

Signature:	/s/ Antoine Papiernik
Name/Title:	Antoine Papiernik
Date:	10/30/2025

Cedric Moreau

Signature:	/s/ Cedric Moreau
Name/Title:	Cedric Moreau
Date:	10/30/2025

Kinam Hong

Signature:	/s/ Kinam Hong
Name/Title:	Kinam Hong
Date:	10/30/2025

Joseph Anderson

Signature:	/s/ Joseph Anderson
Name/Title:	Joseph Anderson
Date:	10/30/2025

Jacques Theurillat

Signature:	/s/ Jacques Theurillat
Name/Title:	Jacques Theurillat
Date:	10/30/2025

FAQ

What did ABVX’s Schedule 13D/A report?

It updated Sofinnova’s holdings and disclosed recent ADS sales, stating 4,334,739 Ordinary Shares and 8,399,478 voting rights as of September 30, 2025.

How much of Abivax (ABVX) does the filer own now?

Approximately 5.6% of Ordinary Shares and 9.4% of voting rights, based on September 30, 2025 outstanding totals.

What transactions were disclosed for ABVX?

On October 28, 2025: 522,948 ADSs at $94.00 and 67,929 ADSs at $95.42. On October 29, 2025: 606,293 ADSs at $94.00 and 2,830 ADSs at $95.34.

What are the outstanding ABVX baselines used?

77,830,067 Ordinary Shares outstanding and 89,189,666 voting rights outstanding, both as of September 30, 2025.

Who are the reporting persons in ABVX’s 13D/A?

Sofinnova Crossover I SLP, Sofinnova Partners SAS, and investment committee members Antoine Papiernik, Cedric Moreau, Kinam Hong, Joseph Anderson, and Jacques Theurillat.

What is the filer’s stated intent regarding ABVX?

Securities were acquired for investment purposes; the filer may buy or sell in accordance with law.